Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track CDT with free AI briefings, catalyst countdowns, and dilution alerts.

CDT · CDT Equity Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$747,000 Cash on Hand
1.8mo Cash Runway
Follow CDT by email Get an email when CDT reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about CDT, unsubscribe in one click. Privacy

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

💰 Cash Runway & Dilution Risk

CDT holds $747,000 in cash and short-term investments (as of Jun 30, 2026) and burns about $1.2M/quarter from operations, an estimated runway of 1.8 months at that rate (BioRadar estimate, not company guidance).

Dilution pressure: 77 · High

Recent financing filings on SEC EDGAR:

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when CDT files for a raise →

👥 Who Owns CDT

Insiders 100% Institutions (5 holders) 0% Public and other holders 0%
HolderTypeShares% of sharesAs of
Nirland Ltd
10% owner
Insider 6,092,000 320.61% 2024-10-03
Andrew Regan
10% owner
Insider 2,064,698 108.66% 2026-11-05
Sarborg Ltd
10% owner
Insider 1,853,933 97.57% 2025-03-31
Manoira Corp
10% owner
Insider 1,347,619 70.92% 2026-10-22
James Bligh
CFO, Director · +1.89M options
Insider 480,024 25.26% 2025-09-19
Ulrik K Olsen
Director
Insider 233,585 12.29% 2026-04-27
Faith L. Charles
Director · +420,000 options
Insider 165,238 8.70% 2025-04-16
Freda C Lewis-Hall
Director · +538,397 options
Insider 38,810 2.04% 2025-08-05
Simon Jeremy Fry
Director · +435,000 options
Insider 36,956 1.94% 2025-08-05
Chele Chiavacci Farley
Director · +2.38M options
Insider 17,157 0.90% 2026-02-19

Share count 1,900,144 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full CDT picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for CDT and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.